Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Deucravacitinib in Psoriasis: Evidence, Gaps, and Place in Therapy
Deucravacitinib in Psoriasis: Evidence, Gaps, and Place in Therapy
Fuente:
Wiley Open Access
Saved in:
Bibliographic Details
Main Authors:
Ece Gokyayla
,
Neslihan Demirel Öğüt
Format:
Artículo Open Access
Published:
Wiley
2025
Subjects:
International Journal of Dermatology
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Internet
https://onlinelibrary.wiley.com/doi/10.1111/ijd.70170
Similar Items
Serum C‐Reactive Protein as a Potential Indicator for Screening Fecal Calprotectin in Patients With Moderate‐to‐Severe Hidradenitis Suppurativa: A Cross‐Sectional Cohort Study
by: Neslihan Demirel Öğüt, et al.
Published: (2025)
Hepatitis B Reactivation in Biologic‐Treated Moderate‐to‐Severe Psoriasis: A Real‐World Cohort Study With 534 Patient‐Years of Follow‐Up
by: Neslihan Demirel Öğüt, et al.
Published: (2026)
Dermatologists' Way of Informative Content About Dermatology and Cosmetology on Social Media
by: Simge Ünal, et al.
Published: (2025)
Rapid Clinical Improvement With Tyrosine Kinase 2 Inhibitor Deucravacitinib in Overlapping Psoriasis and Atopic Dermatitis
by: Jun Ting Tang, et al.
Published: (2025)
The Sustainability of Week 16 Responses to Deucravacitinib Treatment for Patients With Psoriasis
by: Mizuki Shiba, et al.
Published: (2025)